The Biden administration has announced the first 10 medications that will be subject to price negotiations with Medicare under the Inflation Reduction Act.
The Biden administration has revealed the first 10 medications that will be subject to price negotiations between manufacturers and Medicare under the Inflation Reduction Act, according to an Aug. 29 report from CNBC.
The American Hospital Association, which represents 5,000 member hospitals, 270,000 affiliated physicians and 2 million nurses and caregivers, has authored a letter in support of proposed House Resolution 4968, the GOLD Card Act of 2023.
CMS has proposed a new Medicare physician payment schedule for 2024, addressing topics from anesthesia conversion rates to merit-based payment systems.